1. Home
  2. VERU vs ARBK Comparison

VERU vs ARBK Comparison

Compare VERU & ARBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veru Inc.

VERU

Veru Inc.

SELL

Current Price

$2.30

Market Cap

41.9M

Sector

Health Care

ML Signal

SELL

Logo Argo Blockchain plc

ARBK

Argo Blockchain plc

N/A

Current Price

$1.72

Market Cap

42.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VERU
ARBK
Founded
1971
2017
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
41.9M
42.9M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
VERU
ARBK
Price
$2.30
$1.72
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $25.67
N/A
AVG Volume (30 Days)
★ 192.8K
17.0K
Earning Date
08-10-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $16,296,958.00
N/A
Revenue This Year
N/A
$87.00
Revenue Next Year
N/A
$11.66
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.05
$0.12
52 Week High
$7.33
$28.64

Technical Indicators

Market Signals
Indicator
VERU
ARBK
Relative Strength Index (RSI) 43.23 26.27
Support Level $2.12 N/A
Resistance Level $2.78 $3.20
Average True Range (ATR) 0.16 0.16
MACD -0.02 -0.02
Stochastic Oscillator 28.13 0.00

Price Performance

Historical Comparison
VERU
ARBK

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

About ARBK Argo Blockchain plc

Argo Blockchain PLC is a blockchain technology company focused on the large-scale mining of Bitcoin. It mines bitcoin using purpose-built computers (or mining machines) to solve complex cryptographic algorithms on the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company acquires and deploys mining technology solutions in North American facilities that utilize predominantly renewable and inexpensive electricity.

Share on Social Networks: